Technology Current Affairs - 2020
The Council of Scientific and Industrial Research National Health Supply Chain portal called “Arogya Path” was launched to provide real-time availability of health care supplies.
The Arogya path will serve suppliers, manufacturers and customers. It will act as an integrated platform to provide information about key health care goods that help customers to tackle following issues
- Dependence on limited suppliers
- Time-consuming Processes to identify quality products
- Limited access to suppliers that supply standardized products
- Lack of awareness about the current and latest launches.
The National Health Emergency that is currently arising due to COVID-19 is disrupting ability to produce, supply chain disruptions and compromises in delivery of critical items. These issues can be addressed with the help of the portal.
The portal helps suppliers and manufacturers to reach wide network of customers filling in gaps of connectivity between them. Also, it will help to create opportunities of business expansion and identify requirements of new products.
The portal will serve as a platform to generate awareness about the demand for new technologies. It will also help reduce wastage of resources.
Tags: Arogya Path • Council of Scientific and Industrial Research (CSIR) • COVID-19 • Medicines • portal
The Department of Biosciences and Bioengineering and IIT Madras have developed a nasal passage gel that will inactivate COVID1-9. The funding to support the technology is to be provided by SERB (Science and Engineering Research Board), a statutory body operating under Department of Science and Technology.
What is the plan?
The team formed from the two institutes will work on two approaches. They are as follows
Under one approach, the plan is to create a causative agent that will prevent the virus from binding to the host cells. This method will reduce the probability of the host cells being infected. Later the viruses are inactivated using a drug or other technology. This technology will only support prevention of binding.
Another approach is to inactivate the virus by trapping them. This method traps the virus similar to that of detergents. Through the method, the team intends to develop gels that can be applied in the nasal cavity.
The technologies are to be completed in 9 months-time.